Treatment Details – 9.6 months

Survival: 9.6 months
Toxicity Grade:4
Treatments: Chemotherapy
Country:United Kingdom
Hospital:Charing Cross Hospital
Date: 5/2008

Patients: This phase II study involved 63 patients with relapsed malignant pleural mesothelioma. Their median age was 59, ranging from 29 to 77 years old. The majority (93.6%) of patients were men.

Treatment: Patients were treated weekly with the chemotherapy drug vinorelbine.

Toxicity: Grade 3/4 neutropenia was reported in 55% of patients; other, less common grade 3/4 toxicities were anemia, constipation, neuropathy, and phlebitis.

Results: The median overall survival was 9.6 months.

Correspondence: Dr. Justin Stebbing

Get your free copy of
“Surviving Mesothelioma” Today!